Lannett Co Inc News Headlines

LCI 
$36.35
*  
1.29
3.68%
Get LCI Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading LCI now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Lannett Updates on Digoxin Safety Issues, Expands Portfolio - Analyst Blog
8/22/2014 4:50:00 PM - Zacks.com

Lannett To Acquire Two Generic Pharmaceutical Products
8/20/2014 1:22:00 PM - RTT News

Company News for August 19, 2014 - Corporate Summary
8/19/2014 10:10:00 AM - Zacks.com

Why Lannett (LCI) Stock Is Climbing Today
8/18/2014 12:48:00 PM - TheStreet

Lannett Company Sees Q4 EPS Between $0.60 And $0.64 - Quick Facts
8/18/2014 7:42:00 AM - RTT News

Lannett Shares Down on Subpoena Receipt from Connecticut AG - Analyst Blog
7/17/2014 5:10:00 PM - Zacks.com

Weakness Seen in Lannett Company (LCI): Stock Tumbles 17.1% - Tale of the Tape
7/17/2014 8:36:00 AM - Zacks.com

Wednesday Sector Laggards: Drugs, Biotechnology Stocks
7/16/2014 3:35:27 PM - BNK Invest

Wednesday's ETF Movers: GDX, PJP
7/16/2014 3:17:13 PM - BNK Invest

Lannett Co. (LCI) Has Dropped To A 6-Week Low
7/16/2014 10:21:00 AM - RTT News

Cramer's Lightning Round - General Electric Needs To Bring Good Things To Life (7/15/14)
7/16/2014 6:21:00 AM - Seeking Alpha

OncoGenex's Apatorsen in Phase II for Lung Cancer - Analyst Blog
7/7/2014 4:30:00 PM - Zacks.com

Cramer's Lightning Round - People Will Come Back To Charles Schwab (6/5/14)
6/6/2014 5:02:00 AM - Seeking Alpha

After Hours Most Active for Jun 2, 2014 : NOK, TWGP, LCI, FCX, ZQK, QQQ, TWTR, EQT, NPSP, SIRI, REGI, PBCT
6/2/2014 4:39:52 PM - NASDAQ.com News

Lannett: The Long Case Strengthens
5/30/2014 2:26:00 PM - Seeking Alpha

Naysayers Are Wrong: Rohit Vanjani On How To Make Money With Generics, Diagnostics
5/23/2014 4:31:00 PM - Seeking Alpha

Pacira and Patheon Collaborate - Analyst Blog
4/8/2014 6:10:01 PM - Zacks.com

Additional Data on Pacira's Exparel - Analyst Blog
4/8/2014 5:20:01 PM - Zacks.com

Merck KGaA and Auxogyn Collaborate - Analyst Blog
4/4/2014 5:00:01 PM - Zacks.com

Merck KGaA, Pfizer and Broad Institute Collaborate - Analyst Blog
4/3/2014 5:10:01 PM - Zacks.com

Concert Pharmaceuticals (CNCE) Catches Eye: Stock Up 9.3% - Tale of the Tape
4/1/2014 9:25:01 AM - Zacks.com

Abbott's Supera Stent Approved in the U.S. - Analyst Blog
3/31/2014 5:50:01 PM - Zacks.com

Merck KGaA Enrolls First Patient in Study - Analyst Blog
3/28/2014 2:28:01 PM - Zacks.com

Endocyte (ECYT) in Focus: Stock Tumbles 8.3% - Tale of the Tape
3/28/2014 8:47:01 AM - Zacks.com

Update on Eagle Pharma's Ryanodex - Analyst Blog
3/26/2014 12:00:01 PM - Zacks.com